Ahrens Investment Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $203K | Hold |
730
| – | – | 0.1% | 140 |
|
|
2022
Q4 | $202K | Buy |
+730
| New | +$202K | 0.09% | 157 |
|
|
2022
Q3 | – | Sell |
-730
| Closed | -$149K | – | 235 |
|
|
2022
Q2 | $149K | Hold |
730
| – | – | 0.07% | 187 |
|
|
2022
Q1 | $154K | Sell |
730
-10
| -1% | -$2.11K | 0.05% | 213 |
|
|
2021
Q4 | $178K | Hold |
740
| – | – | 0.08% | 201 |
|
|
2021
Q3 | $209K | Hold |
740
| – | – | 0.1% | 193 |
|
|
2021
Q2 | $256K | Hold |
740
| – | – | 0.12% | 186 |
|
|
2021
Q1 | $207K | Buy |
+740
| New | +$207K | 0.1% | 188 |
|
|
2020
Q4 | – | Sell |
-805
| Closed | -$228K | – | 191 |
|
|
2020
Q3 | $228K | Hold |
805
| – | – | 0.15% | 137 |
|
|
2020
Q2 | $215K | Sell |
805
-15
| -2% | -$4.01K | 0.13% | 141 |
|
|
2020
Q1 | $259K | Hold |
820
| – | – | 0.19% | 91 |
|
|
2019
Q4 | $243K | Buy |
+820
| New | +$243K | 0.1% | 138 |
|
|
2019
Q1 | – | Sell |
-790
| Closed | -$238K | – | 174 |
|
|
2018
Q4 | $238K | Sell |
790
-190
| -19% | -$57.2K | 0.11% | 125 |
|
|
2018
Q3 | $346K | Buy |
980
+45
| +5% | +$15.9K | 0.13% | 112 |
|
|
2018
Q2 | $271K | Sell |
935
-7
| -0.7% | -$2.03K | 0.11% | 121 |
|
|
2018
Q1 | $258K | Buy |
942
+2
| +0.2% | +$548 | 0.11% | 113 |
|
|
2017
Q4 | $299K | Hold |
940
| – | – | 0.12% | 104 |
|
|
2017
Q3 | $294K | Hold |
940
| – | – | 0.13% | 97 |
|
|
2017
Q2 | $255K | Hold |
940
| – | – | 0.11% | 110 |
|
|
2017
Q1 | $257K | Hold |
940
| – | – | 0.12% | 105 |
|
|
2016
Q4 | $267K | Buy |
+940
| New | +$267K | 0.14% | 102 |
|